TrialFind
Saved trials
Back to results
Completed
Phase 2
Phase 3
Balugrastim (Neugranin) in Breast Cancer Participants Receiving Doxorubicin/Docetaxel
NCT00837265
What is this trial?
Generating plain-language summary...
Am I eligible?
Generating eligibility summary...
What's involved?
Summarizing study design...
Where and how to apply
View on ClinicalTrials.gov
Official details
Balugrastim (Neugranin) in Breast Cancer Participants Receiving Doxorubicin/Docetaxel — TrialFind